{"name":"Oasis Pharmaceuticals, LLC","slug":"oasis-pharmaceuticals-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-03-15","type":"pipeline","source":"simplywall.st","summary":"Assessing Kobayashi Pharmaceutical (TSE:4967) Valuation After Oasis Management’s Governance Challenge - simplywall.st","headline":"Assessing Kobayashi Pharmaceutical (TSE:4967) Valuation After Oasis Management’s Governance Challenge","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxNY1JaSEFaVnFfU1RFUF85NFdPTWVkNWpVR1V5dXIxSnZiUGZZV0w2andLOEdNSXUza3FUbnl2N1dQZThDYTZ0eXV0a2V3c1JSMjJqek5aNzd1MGY1M1JkNmZreDJ3cWpRTXR4aWZTLXF1cEowS0xoMnJla3NSd1BReEhORDNmRmI5U1djd3lwNDB0UG5kM0ZzMmNxXzJpSE9YNXRyWnVuOFVDb09Ocld3djFIZF9qd2RweUNPeE5xWlVxWlZUdXUwMGlKdUg5NXVsa1E?oc=5","date":"2025-07-30","type":"pipeline","source":"PR Newswire","summary":"THR-β Agonist Market on the Rise: Insights and Projections Upto 2034 | DelveInsight - PR Newswire","headline":"THR-β Agonist Market on the Rise: Insights and Projections Upto 2034 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxPLXA1VDlORlNsSWJ0akRIM1BDUldVcGZuRzJhNjkzMzhVUHhfMHQ4d04tMGtERDlUb0VvMmRHSHdwU3V5ZUxuM1dQb3RLV2xsbUdValpqYTdLbDNtWWZMMVhQZE9maW45V0xleG9pbjhhMFo1RW13cEhBTG9KcTVxRWR1NmVCSG9ZVEgwdVZUMVdGM2p6N2hoYm9zbmpvUWZQUmpwVmQ4blcwQzZMVUhndEQyQ3B5QTJuSi1MX0dMdlo1SXZCbFNZUllpdUpOekJKakJ5TUV6Qm1DSTc2OVBUUlo4eVhmOFJCckpyakpyeXFqVjRCQW9sQTRhd1Y0emtuR1ZrdVJXc2pMV1h1N2VYTl81dHQzalZGQ0xZRXFpSFlwdU53M3c?oc=5","date":"2025-05-13","type":"pipeline","source":"PR Newswire","summary":"Liver Fibrosis Market to Witness Rapid Growth at a CAGR of ~24% During the Forecast Period (2025-2034) with Emerging Treatment Options | DelveInsight - PR Newswire","headline":"Liver Fibrosis Market to Witness Rapid Growth at a CAGR of ~24% During the Forecast Period (2025-2034) with Emerging Tre","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxOaGMwZmh0SWVNM2V1elF0Ykx4R2FyWTc3emlSckwzUmg5QUEtYmpnSDFyQmJiVWI2czhPM1JXdW50UnAyamNOT1FCSXVrNm1ma1BSVldDbnlNbUNleXR4bWRNWmtTZUhyT05DVHlKdDd0S3U5U0dQVXZiV3NJTW5vdkFYSzVOektrVXRBWVplYjQ3UmNVZWd2VVRUQmhHT0k0bjFUVk13NDNETjJmSXh1TFczMm1uWWZJTU1HN25FUWgwdW9mc1ZLWl9iT0RTWWdlWFpkeVpZOWtGUnQ3eWRNUVZZeGJIQ2puSzBTclF5WExQYnAyQktkVWxIbFBQWEtKN1VXZjVTZ21mN1BlZ0QxanJnMmhfeDA2?oc=5","date":"2025-01-30","type":"pipeline","source":"PR Newswire","summary":"Metabolic Dysfunction-Associated Steatohepatitis Market to Register Stunning Growth at a CAGR of 17.9% in the US by 2034 | DelveInsight - PR Newswire","headline":"Metabolic Dysfunction-Associated Steatohepatitis Market to Register Stunning Growth at a CAGR of 17.9% in the US by 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOUF8tTFc0ZzdfUFVqZFBaNE9sZjRhT0FxTXp4cDRlN0lGMWgyZV80UmNYY2RzM18zQlBBMEJYTkg0a0pib2dPYWRSQ1VHR1RES1VJRVIydWZPNnJqWUdfeEVLLVQ5eURnelZ1bVZ0Q2p0bUh4QXhRcWhxbnRxUnNXeTlOQ0d6TWdvY2ZIVTR5bXpqX2tTUFRYbm9xTm4wN0NTaXpNUEp2aFFWQXJG0gGyAUFVX3lxTE1YN3MyZFRieEgtWUVDdnhLVGVzeTNuOU1YU3FNNGdSMFZ1Y19RazZNUVdCUzZtUWdEVnlNcGZFUjgtSkNSb1hFMFkyQUQ5SU5QMnBkSzFlRGlpMkcwVzAzVlc4b21aR1l4RVVTM3d2aWtwazhMVGIxLUlhQXZ0YkpLNU5icnQ5bmxvUlRVZVdpaFVKUkllUndic1NTX2NPUUJSZ3U0R3QzS21Cb1ByT18xNkE?oc=5","date":"2024-08-10","type":"pipeline","source":"CNBC","summary":"Activist Oasis suggests three steps to build shareholder value at embattled Kobayashi Pharmaceutical - CNBC","headline":"Activist Oasis suggests three steps to build shareholder value at embattled Kobayashi Pharmaceutical","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPZFlyUzBoLUdYWjlhcENqejdxYjZub0VTNHlWc0RxR2d3SlpKYjByYThOU3E5WEMtazlhRWhzZkpGazB4c1hIdHNlMnVWWGE3c1E4djhTdXdSczNiM09xNnlrc0g4N2o0SllpQW5Ocmg1RHVNZlJBQV9wTExxM0ViN3hlUU04YWhEZlB0eUVhcUdPVTR0TUsyTUtjQXdyRVdnS3VfaA?oc=5","date":"2024-05-31","type":"trial","source":"Fierce Biotech","summary":"Ionis reveals an oasis for HAE patients as RNA med reduces attacks in phase 3 - Fierce Biotech","headline":"Ionis reveals an oasis for HAE patients as RNA med reduces attacks in phase 3","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxOZVRUM09NbTMwZlBrNENqbXZUTnl1Y0VLajdSZG9iZGdfQ3Nabl95RFJ5R3F3UUVGRURYaFBsTmZRaDdoY21NWmU3WEhZWXBldmFiYk1QeEpjZGlwN2lvWWpvY1QyaUhIQVZ0MU9YOHNjbDR0d3ZSckNWVUZDUkx5dkl0NTAybjVfQ2Z2OVRLbUFKa2hRUEFOZ0lqQjl6aG9QYzJHQkZZNTBLYUdyZXNmcmRFaGhYQ29sOXhZQnJCOGlKa0VOOGR0STZzTFBmZW5QOE0xN3pKMGlLcV9XSFBGMGp4X05EUERPdHRsaE1SdmFBWFloM05vbTZXSFNFdw?oc=5","date":"2024-01-17","type":"pipeline","source":"IANS","summary":"Indo-Asian News Service - IANS","headline":"Indo-Asian News Service","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNZndDVkg4a0t3cHRncDN3M2dYbnFPYWhkblpYVEJod2FPNF94blJwa3hkY0JCaU5BdDF4ZUJKc3p5eFZwWk95ZnRQUGQ0REhHSUVjUDVINmg1dkFlNXhsWS1wR0hDbDI2dlltd3RVTHFaNGRfVlJ0blkzZXZSeGFWR2R5Yng4NWRWS016N2lSbHlBZ2prU25nUmdrcVZNUi1V?oc=5","date":"2022-10-17","type":"deal","source":"The Business Journals","summary":"Deals of the Year: Alora Pharmaceutical buys Osmotica Pharmaceutical for $111M - The Business Journals","headline":"Deals of the Year: Alora Pharmaceutical buys Osmotica Pharmaceutical for $111M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPcXpLY0IwQk5QNFNxeDBTTU1ac1NEbEZFQkR0LVREa1hraXNWU1ExcXlESTNZQXRNZmNRQ3dvcVNRZ19LSjdDcGxvdnJRdExuNVV2bE5wQjlickFXdms2LUk4U3o3ZVNOcUMtU1U1S0FOM3VvX2stSkRCdjF6Vk9xSndRMXA5ZE56OWVnV0RjLS1HX254cDV6YWhXQ0x6U0xya1VF?oc=5","date":"2020-01-03","type":"pipeline","source":"The Business Journals","summary":"15 storylines to watch in the '20s: Oasis in the Triad - The Business Journals","headline":"15 storylines to watch in the '20s: Oasis in the Triad","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOcDlfQnByajM5V0tsMWQ3QmVaZlBZeDI5OS1RZXhuSzdvcHROYzRQRFFWYzh6eVpRZFpoZEdQMl9LVFpkekZKZFQ4RTZiMVBSU3ZLNHZlYWlNVnNSTTJvclVPV0U0eW91di1XQVYxQkZVQks5eHdZdVV1MndtRkwyaFduaVEwUGhrWVZmc05n?oc=5","date":"2014-04-02","type":"pipeline","source":"Ark Invest","summary":"Pharmaceutical Industry: Can In-Silico Drug Discovery Hep? - Ark Invest","headline":"Pharmaceutical Industry: Can In-Silico Drug Discovery Hep?","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}